Agomab Therapeutics NV

AGMB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
2
SEC Filings

2 total filings indexed. 2 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0002020932
TickerAGMB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedC9

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 00276cfe305d10969c7897bcb8157d7921e24552a61813b7673ed2821ce0dd78
parent: root
content hash: a20fe6b271c10c557467dbfc947457b236e2f0de7894d3423bc329d1f54073e5
signed: 2026-04-13T04:43:31.241Z
sources: 0 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf